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Does surgery induce angiogenesis in breast
cancer? Supporting evidence from Africa
Dear Editor
Retsky et al.1 have made a possible induction of
angiogenesis by surgery in young women with
breast cancer. Our clinical experience with manag-
ing young breast cancer patients in Africa seems to
support these observations. All our patients are
usually unscreened and over 70% are under the
age of 45 years. In one institution, the 5-year sur-
vival was as low as 15% with most of the deaths oc-
curring within the first 24 months.2 Furthermore,
in late stage breast cancer, we have also observed
unexplained rapid deterioration and death follow-
ing palliative surgery and chemotherapy.3 In the
light of the study by Retsky et al., these observa-
tions may be related to molecular events triggered
by surgery and/or chemotherapy.
I agree with this study that we need to know for
sure if we are hastening young women’s death
without ‘‘curative surgeries’’. The key weakness of
this study is the fact that it is retrospective, and
the evidences used are indirect. To give strength
to their observations, there is an urgent need
for case controlled, clinical and molecular studies
to outline the exact role of angiogenesis in post-
surgical breast cancer recurrence and mortality.
Considering the heterogeneous nature of breast
cancer, we need to also look at other prognostic
molecular markers to see if surgery up-regulates
them as well.
I do not agree that we have enough evidence to
change or reconsider our practice as regards early
detection and surgical management of young
women with breast cancer. We need to await
further multicenter, prospective case controlled
studies to make such moves.
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Letters to the Editor 289Surgery-induced angiogenesisDear Editor
I read with great interest the paper by Retsky
et al. (2005) published in the IJS.1 The authors
present impressive data suggesting that the mam-
mography paradox of breast cancer screening and
the early postoperative relapses in younger women
are due to surgery-induced angiogenesis in these
tumours. Angiogenesis (or neovascularization) is
the process whereby new vasculature is recruitedfrom pre-existing vessels2 and there is no doubt
that a stimulation of the angiogenic process can in-
crease the rate of tumour growth.3
Retsky et al. (2005) used computer simulations to
analyze data from 1173 pre- and post-menopausal,
node-negative and positive breast cancer patients
treated by surgery alone and with 16e20 years
follow-up. They found that pre-menopausal
node-positive women had twice the relapse rate
as post-menopausal node-positive women. They
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surgery. However, even if surgery does lead to an
induction of angiogenesis, it is unlikely that this
would translate into a worsening of mortality in
such a short time period. Also, it is quite possible
that age is an independent prognostic factor in
breast cancer, as is the case in prostate cancer
where generally younger men have more aggres-
sive disease even if their grade, stage, and PSA put
them in a low risk category.
However, there is an increasing evidence base
that surgery-induced angiogenesis is a real effect.
A study by Wu et al.4 in colorectal cancer patients
found that levels of endostatin (an anti-angiogenic
factor) fell in the immediate postoperative period,
and this was also accompanied by a transient rise in
vascular endothelial growth factor (VEGF; the most
potent pro-angiogenic factor known). Also, growth
factors released in the immune response to surgery
may also stimulate angiogenesis. A paper by Brivio
et al.5 found that pre-surgical IL-2 immunotherapy
for colorectal cancer patients reduced the postop-
erative increase in VEGF. These authors also found
that IL-12 (a known anti-angiogenic cytokine)
levels decreasedafter surgery, and that IL-2 therapy
abrogated this decline, further suggesting that
the immune response after surgery might be re-
sponsible for accelerating angiogenesis.
I am myself planning a study of neo-adjuvant
anti-angiogenic therapy in prostate cancer pa-
tients to assess the effect this has on plasma
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Dear Editor
The phenomena documented by Retsky1 is ap-
parently something that may have been long rec-
ognized by some AfricaneAmerican women who
attributed it to reasons that were never medically
validated.
As a child overhearing conversations about this
dreadful health condition, there was always the
warning to ‘‘avoid surgery because exposing the
cancer to air would make it grow stronger or inangiogenic biomarkers measured by ELISA. Follow-
ing the data presented by Retsky et al. (2005)
a similar study is therefore now warranted in
breast cancer.
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other places in the body.’’ Of course, that was
a mere suspicion to explain what they actually
saw happening amongst friends and family. In fact,
I can recall two acquaintances of my family who,
after removal of malignant breast tumors, de-
veloped brain cancer shortly thereafter.
Despite any negative responses that you may be
incurring as a result of your recently published
article on breast cancer, I hope you will continue
with your efforts. I truly believe there is something
to your theory.
